Victory Capital Management Inc. Has $2.86 Million Holdings in Maximus, Inc. (NYSE:MMS)

Victory Capital Management Inc. lessened its position in Maximus, Inc. (NYSE:MMS - Free Report) by 95.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 38,297 shares of the health services provider's stock after selling 884,315 shares during the quarter. Victory Capital Management Inc. owned 0.07% of Maximus worth $2,859,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Atria Investments Inc purchased a new position in shares of Maximus in the 3rd quarter worth approximately $244,000. Crossmark Global Holdings Inc. lifted its stake in Maximus by 9.8% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 4,152 shares of the health services provider's stock valued at $387,000 after acquiring an additional 369 shares during the period. Entropy Technologies LP acquired a new stake in Maximus during the 3rd quarter valued at approximately $214,000. Natixis Advisors LLC acquired a new position in shares of Maximus in the 3rd quarter valued at $955,000. Finally, Quest Partners LLC lifted its stake in shares of Maximus by 95.2% in the 3rd quarter. Quest Partners LLC now owns 37,488 shares of the health services provider's stock valued at $3,492,000 after purchasing an additional 18,286 shares during the period. Institutional investors own 97.21% of the company's stock.

Maximus Stock Up 1.3 %

Maximus stock traded up $0.88 during mid-day trading on Monday, hitting $67.99. The company had a trading volume of 623,762 shares, compared to its average volume of 479,922. The business has a fifty day moving average of $71.83 and a 200 day moving average of $79.13. The stock has a market cap of $3.85 billion, a price-to-earnings ratio of 14.62 and a beta of 0.71. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Remove Ads

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, sell-side analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.76%. The ex-dividend date of this dividend was Friday, February 14th. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Insider Buying and Selling

In related news, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares of the company's stock, valued at $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Bruce Caswell bought 3,500 shares of the firm's stock in a transaction that occurred on Tuesday, December 17th. The shares were purchased at an average cost of $70.64 per share, with a total value of $247,240.00. Following the purchase, the chief executive officer now directly owns 275,929 shares of the company's stock, valued at approximately $19,491,624.56. This represents a 1.28 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.60% of the company's stock.

Analyst Ratings Changes

MMS has been the subject of several recent analyst reports. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a report on Thursday, January 2nd. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.